Showing results (1-10 of 117) with videos related to
Sort By:
Pageof 12
Autophagy Reports|March 4, 2024
Targeting autophagy to treat HIV immune dysfunctionWenli Mu, Heather Martin, Anjie ZhenViruses|June 27, 2025
Finetuning Type I Interferon Signaling to Enhance T Cell Immunity in HIV InfectionWenli Mu, Nandita Kedia, Anjie ZhenJournal of Visualized Experiments : Jove|October 25, 2022
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized MiceWenli Mu, Anjie Zhen, Mayra A Carrillo, et al.Viruses|February 24, 2024
Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV InfectionWenli Mu, Vaibhavi Patankar, Scott Kitchen, et al.Trends in Biotechnology|January 6, 2026
CRISPR/Cas strategies to enhance CAR T-cell function and persistence via metabolic reprogrammingMargaret R Wang, Wenli Mu, Anjie Zhen, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 28, 2024
Stem cell-derived CAR T cells show greater persistence, trafficking, and viral control compared to ex vivo transduced CAR T cellsMayra A Carrillo, Anjie Zhen, Wenli Mu, et al.Frontiers in Immunology|October 17, 2022
Cannabidiol modulates expression of type I IFN response genes and HIV infection in macrophagesShallu Tomer, Wenli Mu, Gajendra Suryawanshi, et al.Plos Pathogens|August 30, 2021
Correction: Robust CAR-T memory formation and function via hematopoietic stem cell deliveryAnjie Zhen, Mayra A Carrillo, Wenli Mu, et al.Plos Pathogens|April 1, 2021
Robust CAR-T memory formation and function via hematopoietic stem cell deliveryAnjie Zhen, Mayra A Carrillo, Wenli Mu, et al.JCI Insight|December 12, 2022
Autophagy inducer rapamycin treatment reduces IFN-I-mediated Inflammation and improves anti-HIV-1 T cell response in vivoWenli Mu, Valerie Rezek, Heather Martin, et al.Pageof 12